Lunai Bioworks
LNAI
40 hedge funds and large institutions have $3.02M invested in Lunai Bioworks in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
11% more funds holding
Funds holding: 36 → 40 (+4)
0.01% less ownership
Funds ownership: 0.09% → 0.07% (-0.01%)
19% less capital invested
Capital invested by funds: $3.73M → $3.02M (-$703K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$170K |
| 2 |
N
Natixis
Paris,
France
|
+$65.7K |
| 3 |
HF
HRT Financial
New York
|
+$42.6K |
| 4 |
Goldman Sachs
New York
|
+$15.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$480K |
| 2 |
CF
Cantor Fitzgerald
New York
|
-$62K |
| 3 |
Two Sigma Investments
New York
|
-$36.9K |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$26K |
| 5 |
Belvedere Trading
Chicago,
Illinois
|
-$24.3K |
LNAI Hedge Fund Activity: Q1 2023 in Review
40 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q1 2023, worth a combined $3.02M — down 19% from $3.73M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new LNAI positions and 3 closed out — a net gain of 4 holders — while 15 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $170K. The largest seller was Vanguard Group, cutting an estimated $480K.
- 40 institutional investors held Lunai Bioworks (LNAI) as of Q1 2023, up from 36 in Q4 2022.
- Funds reported $3.02M of Lunai Bioworks stock for Q1 2023, down 19% quarter-over-quarter.
- 7 funds opened new Lunai Bioworks positions in Q1 2023 and 3 closed out, a net change of +4 holders.
- The largest Lunai Bioworks buyer in Q1 2023 was BlackRock, an estimated $170K added.
- The largest Lunai Bioworks seller in Q1 2023 was Vanguard Group, an estimated $480K sold.
Based on aggregated 13F filings for Q1 2023.